CN105085365B - The preparation method of bazedoxifene acetate and its intermediate - Google Patents

The preparation method of bazedoxifene acetate and its intermediate Download PDF

Info

Publication number
CN105085365B
CN105085365B CN201410199104.XA CN201410199104A CN105085365B CN 105085365 B CN105085365 B CN 105085365B CN 201410199104 A CN201410199104 A CN 201410199104A CN 105085365 B CN105085365 B CN 105085365B
Authority
CN
China
Prior art keywords
bazedoxifene acetate
formula
reaction
acetate intermediate
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410199104.XA
Other languages
Chinese (zh)
Other versions
CN105085365A (en
Inventor
阳海
姚中伟
葛建华
王利春
胡思玉
赵栋
王晶翼
程志鹏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sichuan Kelun Pharmaceutical Co Ltd
Original Assignee
Sichuan Kelun Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan Kelun Pharmaceutical Co Ltd filed Critical Sichuan Kelun Pharmaceutical Co Ltd
Priority to CN201410199104.XA priority Critical patent/CN105085365B/en
Publication of CN105085365A publication Critical patent/CN105085365A/en
Application granted granted Critical
Publication of CN105085365B publication Critical patent/CN105085365B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses the preparation methods of bazedoxifene acetate intermediate and bazedoxifene acetate intermediate.The invention also discloses the methods that bazedoxifene acetate is prepared with bazedoxifene acetate intermediate.The present invention provides preparing shown in bazedoxifene acetate key new intermediate such as formula (II), the intermediate is with C1‑6Alkanoyl is protecting group, and preparing bazedoxifene acetate using the intermediate has the following advantages:1st, the high-pressure hydrogenation hydrogenation that conventional method (protecting phenolic group by blocking group of benzyl) sloughs high risk required during protecting group is avoided, greatly reduces experimental risk;2nd, the reaction time has been saved, has reduced industrial energy consumption;3rd, reaction of the invention does not need to the palladium carbon of larger proportion amount, and reaction condition is mild, easy to operate, environmentally friendly, is suitble to industrialized production.

Description

The preparation method of bazedoxifene acetate and its intermediate
Technical field
The present invention relates to the preparation methods of a kind of drug and its intermediate, are dredged more particularly to sclerotin after treatment postmenopausal women The preparation method of loose drug bazedoxifene acetate and its intermediate.
Background technology
Entitled 1- { 4- [2- (cycloheximide base -1-) ethoxies of bazedoxifene acetate (bazedoxifene acetate) chemistry Base] benzyl } -2- (4- hydroxy phenyls) -3- Methyl-1H-indole -5- phenol acetate is by European Ligand companies affiliate Wyeth is in the selective estrogen receptor modulators (SERM) of research and development in 1997, in 2010 in Spain's (trade name Conbriza) and Japanese (trade name Viviant) listing, indication are prevention and treatment women's osteosporosis after menopause.
Osteoporosis can betide different sexes and age, but be more common in postmenopausal women and elderly men.Post menopausal Osteoporosis (Postmenopausal Osteoporosis, POP) is a kind of common disease related with aging, main to occur In postmenopausal women, since estrogen deficiency leads to bone amount reduction and bone structure variation, increase bone brittleness and be easy to fracture, And the pain as caused by fracture, textured bone, occur complication so that it is dead the problems such as, belong to primary osteoporosis. Primary national extensive epidemiological survey in 2003 to 2006 shows that 50 years old or more crowd is close with centrum and femoral neck bone Osteoporosis total prevalence rate women based on angle value is 20.7%.The epidemiological survey of the area based on iconography such as Beijing It has been shown that, the illness rate of 50 years old or more women's spinal fracture is 15%, is equivalent in every 7 50 years old or more women with regard to there are one occur Cross spinal fracture.The danger (40%) of osteoporotic fracture occurs all over the body for women, higher than breast cancer, carcinoma of endometrium and ovum The summation of nest cancer.
Treatment postmenopausal osteoporosis drug mainly has:1st, bisphosphonates (Bisphosphonates);2nd, estrogens (Estrogen);3rd, parathyroid hormone (PTH);4th, selective estrogen receptor modulators class (SERMs);5th, active vitamin D and the like.
Different medicines has Diphosphonate, strontium ranelate and nearest new drug denomsumab, there is certain change The effect of kind postmenopausal osteoporosis, but and not all women be suitable for.It is hidden due to the use of the health caused by these drugs Suffer from, such as the cancer of the esophagus, lower jaw osteonecrosis;Use fracture subtrochanteric after Diphosphonate;It may lead to vein using Strontium Ranelate Embolism;The discovery of Bazedoxifene can increase the selection of osteoporosis therapy scheme, and this new selective estrogen by Body conditioning agent may have stronger anti-osteoporosis potentiality.
In recent years, people are continuing to optimize and are improving always the synthesis technology of bazedoxifene acetate, the patent reported for work recently US2012253038A1, WO2009012734A etc. using bromo- (4- benzyloxy-phenyls) acetone of 2- and to benzyloxy aniline hydrochloride as Starting material passes throughSynthesis of indole ring is reacted, seven yuan of azacyclo-s on parental materials, then hydrogenated reaction Debenzylation protecting group obtains Bazedoxifene.The main route of synthesis bazedoxifene acetate is as follows at present:
This method protects phenolic group by blocking group of benzyl, during hydrogenation debenzylation blocking group, needs to be more than 3MPa High-pressure hydrogenation kettle, in experiment exist very big danger.The reaction time generally needs 4-7 days, and the reaction time is longer, raw It consumes energy in production larger, and the palladium carbon of larger proportion amount is needed in reacting, expensive to increase cost, post processing trouble is to environment It is seriously polluted.
Invention content
First of the present invention is designed to provide new bazedoxifene acetate intermediate.
Second object of the present invention is to provide the method for preparing above-mentioned bazedoxifene acetate intermediate.The intermediate Preparation is to be passed through with formula (II-a) and formula (II-b) for starting materialReact synthesis of indole ring.
Third object of the present invention is to provide prepares bazedoxifene acetate with above-mentioned bazedoxifene acetate intermediate Method.
As the first aspect of the invention, shown in the structure such as formula (II) of the bazedoxifene acetate intermediate,
Wherein R1And R3It is C1-6Alkanoyl, and R1And R3It is identical or different.
Preferably, shown in the structure such as formula (II) of the bazedoxifene acetate intermediate, wherein R1For acetyl group or fourth Acyl group, R3For acetyl group or propiono.
It is that the bazedoxifene acetate intermediate is 3- methyl -5- bytyries -2- as present invention further optimization (4- propionyloxies phenyl) -1H- indoles, wherein R1For bytyry, R3For propiono.
It is that the bazedoxifene acetate intermediate is 3- methyl -5- acetyl group -2- as present invention further optimization (4- propionyloxies phenyl) -1H- indoles, wherein R1For acetyl group, R3For propiono.
It is that bazedoxifene acetate intermediate is 3- methyl -5- acetyl group -2- (4- second as present invention further optimization Phenyl) -1H- indoles (formula (II -1)), wherein R1And R3It is acetyl group.
As the second aspect of the invention, the method for preparing above-mentioned bazedoxifene acetate intermediate includes the following steps:
Wherein, R2For C1-6Alkanoyl, R2Preferably acetyl group, propiono or bytyry.
In the preparation method, formula (II-a) and formula (II-b) carry out instead in the presence of polar non-solute and organic base It should.
As present invention further optimization, the reaction reacts 8-12h at 90-130 DEG C;Further preferably, it is described Reaction reacts 10h at 110 DEG C.
As present invention further optimization, the polar non-solute is n,N-Dimethylformamide, N- methyl pyrroles The one or more of pyrrolidone, 1,4- dioxane or dimethyl sulfoxide (DMSO).The polar non-solute is preferably N, N- diformazans Base formamide.
As present invention further optimization, the organic base is triethylamine, diisopropyl ethyl amine, tripropyl amine (TPA) or three fourths The one or more of amine;Preferably triethylamine.
As present invention further optimization, the molar feed ratio of the formula (II-a) and formula (II-b) is 1:1-2.5;It is excellent It is selected as 1:1.5-2.5;Further preferably 1:2.2.
As present invention further optimization, the volume ratio of the polar non-solute and organic base is 3-8:1, preferably For 4-6:1, further preferably 5:1.
The synthetic method of the bazedoxifene acetate intermediate is with C1-6Alkanoyl protects phenolic group for blocking group, passes throughReact synthesis of indole ring.
As present invention further optimization, the formula (II-a) is 4 '-acetyl group -2- brom-acetophenones (II-a1), wherein R1For acetyl group;The formula (II-b) is N- (to acetoxyl group) phenyl-acetamides (II-b1), wherein R2、R3It is acetyl group.
As present invention further optimization, the formula (II-a) be 4 '-bytyry -2- brom-acetophenones, wherein R1For fourth Acyl group;The formula (II-b) be N- (to propionyloxy) Phenylpropionamide, wherein R2、R3It is propiono.
As present invention further optimization, the formula (II-a) be 4 '-acetyl group -2- brom-acetophenones, wherein R1For second Acyl group;The formula (II-b) be N- (to propionyloxy) phenylbutanamides, wherein R2For bytyry, R3For propiono.
As the third aspect of the invention, the side of bazedoxifene acetate is prepared with above-mentioned bazedoxifene acetate intermediate Method includes the following steps:
(1) formula (II) and formula (II-c) are alkylated reaction, reaction knot in the presence of NaH and polar non-solute Shu Hou adds in aqueous slkali and obtained formula (III) is hydrolyzed;
(2) formula (III) forms formula (I) in the presence of ascorbic acid and organic solvent with acetic acid reaction.
As present invention further optimization, it is in the step (1) Chinese style (II) and the molar feed ratio of formula (II-c) 1:0.8-1.5, preferably 1:1-1.3 further preferably 1:1.2.
As present invention further optimization, step (1) Chinese style (II) reacts 10- with formula (II-c) at 20-30 DEG C 15h, preferably 25 DEG C reaction 15h.
As present invention further optimization, the polar non-solute is selected from n,N-Dimethylformamide, Isosorbide-5-Nitrae-two Six ring of oxygen, N-Methyl pyrrolidone, dimethyl sulfoxide (DMSO) one or more;The polar non-solute used is preferably N, N- bis- Methylformamide.
As present invention further optimization, the inorganic base described in the step (1) is selected from sodium hydroxide, hydroxide Potassium, potassium carbonate, cesium carbonate one or more;The inorganic base used is preferably sodium hydroxide or potassium hydroxide.
As present invention further optimization, the organic solvent described in the step (2) is selected from ethyl acetate, isopropyl acetate Ester, isopropanol, acetonitrile, methyl tertiary butyl ether(MTBE) one or more;The organic solvent used is preferably isopropanol.
As present invention further optimization, the step (2) reacts 2-5h at 50-60 DEG C;Preferably 60 DEG C reaction 3h.
Bazedoxifene is synthesized by C1-6Seven yuan on the bazedoxifene acetate intermediate parental materials of alkanoyl protecting group Azacyclo-, then alkaline water frees C again1-6Alkanoyl protecting group, avoids high-pressure hydrogenation, reduces the danger of experiment.
The C of the present invention1-6Alkanoyl includes acetyl group, propiono, bytyry, valeryl and acyl group.
Compared with prior art, the present invention has the advantages that:
The present invention provides the method for preparing bazedoxifene acetate new intermediate (as shown in formula (II)), preparations of the invention Method substrate is with C1-6Alkanoyl protects phenolic group for blocking group, passes throughSynthesis of indole ring is reacted, this is anti- Should have many advantages, such as that reaction condition is mild, yield is high.
Bazedoxifene acetate intermediate formula (II) using the present invention prepares bazedoxifene acetate and has the following advantages:1st, it keeps away The high-pressure hydrogenation hydrogen that conventional method (protecting phenolic group by blocking group of benzyl) sloughs high risk required during protecting group is exempted from Change reaction, greatly reduce experimental risk;2nd, the reaction time has been saved, has reduced industrial energy consumption;3rd, reaction of the invention is not required to The palladium carbon of larger proportion amount is wanted, reaction condition is mild, easy to operate, environmentally friendly, is suitble to industrialized production.
Specific embodiment
With reference to specific embodiment, the present invention is described in further detail, but is not defined to protection domain The embodiment.
The preparation of the intermediate (formula II) of bazedoxifene acetate
Embodiment 1:The preparation of 3- methyl -5- acetyl group -2- (4- acetoxyl groups phenyl) -1H- indoles (formula (II-1))
Method A
By the 4 ' of 270g-acetyl group -2- brom-acetophenones (II-a1), N- (to acetoxyl group) phenyl-acetamides of 425g (II-b1), the n,N-Dimethylformamide of 1350ml and 270ml triethylamines input reaction kettle in, be heated with stirring to 110 DEG C of reactions 10h.TLC detections are cooled to room temperature, reaction solution are poured into 540ml ice water after the reaction was complete, stir 1h, filter, and solid is with 50 DEG C methanol mashing washing, 40 DEG C of forced air dryings of obtained solid for 24 hours, obtain 271g brown solids, yield:84%.
MS:M/z=324 [M+1]+
1HNMR(DMSO-d6):2.04-2.16ppm(s,6H),2.30ppm(s,3H),7.0ppm(dd,2H),7.13ppm (dd,2H),7.20ppm(d,1H),7.45ppm(dd,2H),9.58ppm(s,1H)。
Method B
By the 4 ' of 270g-acetyl group -2- brom-acetophenones (II-a1), N- (to acetoxyl group) phenyl-acetamides of 193g (II-b1), Isosorbide-5-Nitrae-dioxane of 1080ml and 270ml triethylamines input reaction kettle in, be heated with stirring to 90 DEG C reaction 12h. TLC detections are cooled to room temperature, reaction solution are poured into 540ml ice water after the reaction was complete, stir 1h, filter, solid is with 50 DEG C Methanol mashing washing, 40 DEG C of forced air dryings of obtained solid for 24 hours, obtain 242g brown solids, yield:75%.
Method C
By the 4 ' of 270g-acetyl group -2- brom-acetophenones (II-a1), N- (to acetoxyl group) phenyl-acetamides of 290g (II-b1), the dimethyl sulfoxide (DMSO) of 1620ml and 270ml triethylamines input reaction kettle in, be heated with stirring to 130 DEG C reaction 8h.TLC Detection is cooled to room temperature, reaction solution is poured into 540ml ice water after the reaction was complete, stirs 1h, filters, 50 DEG C of first of solid Alcohol mashing washing, 40 DEG C of forced air dryings of obtained solid for 24 hours, obtain 234g brown solids, yield:80%.
Method D
By the 4 ' of 270g-acetyl group -2- brom-acetophenones (II-a1), N- (to acetoxyl group) phenyl-acetamides of 482g (II-b1), the N-Methyl pyrrolidone of 2160ml and 270ml diisopropyl ethyl amines input reaction kettle in, be heated with stirring to 120 DEG C reaction 10h.TLC detections are cooled to room temperature, reaction solution are poured into 540ml ice water after the reaction was complete, stir 1h, filter, Gu Body is beaten washing with 50 DEG C of methanol, and 40 DEG C of forced air dryings of obtained solid for 24 hours, obtain 226g brown solids, yield:70%.
Embodiment 2:The preparation of 3- methyl -5- bytyries -2- (4- propionyloxies phenyl) -1H- indoles
By the 4 ' of 300g-bytyry -2- brom-acetophenones, N- (to propionyloxy) Phenylpropionamide of 440g, 2100ml In Isosorbide-5-Nitrae-dioxane and 420ml triethylamines input reaction kettle, it is heated with stirring to 110 DEG C of reaction 10h.The reaction was complete for TLC detections Afterwards, room temperature is cooled to, reaction solution is poured into 600ml ice water, stirs 1h, is filtered, solid is beaten washing, institute with 50 DEG C of methanol It obtains 40 DEG C of forced air dryings of solid for 24 hours, obtains 275g brown solids, yield 75%.
MS:M/z=366 [M+1]+
1HNMR(DMSO-d6):1.03-1.12ppm(t,6H),1.60ppm(s,2H),2.23-2.29ppm(m,4H), 2.32ppm(s,3H),7.06ppm(dd,2H),7.18ppm(dd,2H),7.24ppm(d,1H),7.47ppm(dd,2H), 9.86ppm(s,1H)。
Embodiment 3:The preparation of 3- methyl -5- acetyl group -2- (4- propionyloxies phenyl) -1H- indoles
By the 4 ' of 270g-acetyl group -2- brom-acetophenones, N- (to propionyloxy) phenylbutanamides of 423g, 2100ml In n,N-Dimethylformamide and 420ml triethylamines input reaction kettle, it is heated with stirring to 110 DEG C of reaction 10h.TLC detection reactions After completely, room temperature is cooled to, reaction solution is poured into 600ml ice water, stir 1h, filtered, solid is washed with 50 DEG C of methanol mashing It washs, 40 DEG C of forced air dryings of obtained solid for 24 hours, obtain 257g brown solids, yield:70%.
MS:M/z=338 [M+1]+
1HNMR(DMSO-d6):1.13ppm(t,3H),2.09ppm(s,3H),2.25ppm(m,2H),2.33ppm(s, 3H),7.0ppm(dd,2H),7.13ppm(dd,2H),7.20ppm(d,1H),7.45ppm(dd,2H),10.01ppm(s,1H)。
The preparation of Bazedoxifene (formula III)
Embodiment 4:1- { 4- [2- (hexamethylene ammonia) ethyoxyl] benzyl } -2- (4- hydroxy phenyls) -3- methyl -5- hydroxyls The preparation of base-indoles
Method I
In the n,N-Dimethylformamide input reaction kettle that the 60%NaH of 72g and 1500ml is dried, -5 DEG C are cooled to, Nitrogen is protected.3- methyl -5- acetyl group -2- (4- acetoxyl groups the phenyl) -1H- indoles (formula (II -1)) of 300g is dissolved in It in the n,N-Dimethylformamide of 800ml, instills in above-mentioned reaction solution, dropping temperature control continues in 0-5 DEG C, completion of dropwise addition Stir 2h.1- [2- (4- chloromethyls) Phenoxyethyl] azepan hydrochloride (formula (II-c)) of 405g is dissolved in 1600ml N,N-Dimethylformamide in, instill above-mentioned reaction solution, 0-5 DEG C of dropping temperature, drop controlled to rise to 25 DEG C after finishing, stirs 15h. After TLC detection raw materials disappear, stop reaction, 300ml 48 grams of sodium hydroxides of water, 25 DEG C of stirrings 15h, TLC are added in into reaction solution Detection the reaction was complete, above-mentioned solution is slowly poured into the ice water of 5000ml, stir 2h, filtering, obtained solid with water rinse to Washing lotion is neutral, and drying obtains 291 grams of solids, yield:89%.
Method II
In the Isosorbide-5-Nitrae that the 60%NaH of 72g and 1500ml is dried-dioxane input reaction kettle, -5 DEG C are cooled to, nitrogen Protection.3- methyl -5- acetyl group -2- (4- acetoxyl groups the phenyl) -1H- indoles (formula (II -1)) of 300g is dissolved in 800ml's It in Isosorbide-5-Nitrae-dioxane, instills in above-mentioned reaction solution, dropping temperature control continues to stir 2h in 0-5 DEG C, completion of dropwise addition.It will 1- [2- (4- chloromethyls) Phenoxyethyl] azepan hydrochloride (formula (II-c)) of 337g is dissolved in the 1,4- bis- of 1600ml In six ring of oxygen, above-mentioned reaction solution is instilled, 0-5 DEG C of dropping temperature, drop is controlled to rise to 30 DEG C after finishing, stirs 10h, TLC detection raw materials After disappearance, stop reaction, 300ml 67 grams of potassium hydroxide of water are added in into reaction solution, 25 DEG C of stirring 15h, TLC detections have been reacted Entirely, above-mentioned solution is slowly poured into the ice water of 5000ml, stirs 2h, filtering, obtained solid is rinsed to washing lotion neutrality with water, dried It is dry to obtain 271.7 grams of solids, yield:83%.
Method III
In the N-Methyl pyrrolidone input reaction kettle that the 60%NaH of 72g and 1500ml is dried, -5 DEG C are cooled to, nitrogen Gas shielded.3- methyl -5- bytyries -2- (4- propionyloxies phenyl) -1H- indoles of 300g is dissolved in the N- methyl pyrroles of 800ml It in pyrrolidone, instills in above-mentioned reaction solution, dropping temperature control continues to stir 2h in 0-5 DEG C, completion of dropwise addition.By the 1- of 447g [2- (4- chloromethyls) Phenoxyethyl] azepan hydrochloride (formula (II-c)) is dissolved in the N-Methyl pyrrolidone of 1600ml In, above-mentioned reaction solution is instilled, 0-5 DEG C of dropping temperature, drop is controlled to rise to 20 DEG C after finishing, stirs 15h.After TLC detection raw materials disappear, Stop reaction, 300ml 118 grams of potassium carbonate of water are added in into reaction solution, the reaction was complete for 25 DEG C of stirring 15h, TLC detections, will be above-mentioned Solution is slowly poured into the ice water of 5000ml, stirs 2h, filtering, and obtained solid is rinsed with water to washing lotion neutrality, and drying obtains 256 Gram solid, yield:78%.
Method IV
In the dimethyl sulfoxide (DMSO) input reaction kettle that the 60%NaH of 72g and 1500ml is dried, -5 DEG C are cooled to, nitrogen is protected Shield.3- methyl -5- acetyl group -2- (4- propionyloxies phenyl) -1H- indoles of 300g is dissolved in the dimethyl sulfoxide (DMSO) of 800ml, It instills in above-mentioned reaction solution, dropping temperature control continues to stir 2h in 0-5 DEG C, completion of dropwise addition.By 1- [2- (the 4- chloromethanes of 388g Base) Phenoxyethyl] azepan hydrochloride (formula (II-c)) is dissolved in the dimethyl sulfoxide (DMSO) of 1600ml, instill above-mentioned reaction Liquid controls 0-5 DEG C of dropping temperature, drop to rise to 25 DEG C after finishing, stirs 12h.After TLC detection raw materials disappear, stop reaction, to reaction 300ml 160 grams of cesium carbonates of water are added in liquid, the reaction was complete for 25 DEG C of stirring 15h, TLC detections, and above-mentioned solution is slowly poured into In the ice water of 5000ml, 2h, filtering are stirred, obtained solid is rinsed with water to washing lotion neutrality, and drying obtains 263.4 grams of solids, receives Rate:80%.
The preparation of bazedoxifene acetate (formula I)
Embodiment 5:1- { 4- [2- (hexamethylene ammonia) ethyoxyl] benzyl } -2- (4- hydroxy phenyls) -3- methyl -5- hydroxyls The preparation of base-indoleacetic acid salt
Method I
By 150 grams of 1- { 4- [2- (hexamethylene ammonia) ethyoxyl] benzyl } -2- (4- hydroxy phenyls) -3- methyl -5- hydroxyls In the ascorbic acid input reaction kettle of base-indoles (formula (III)), 3000ml isopropanols and 1.5g, nitrogen protection is heated to reflux molten Solution filters off insoluble matter, and 29g glacial acetic acid is instilled in filtrate, and drop keeps 60 DEG C of stirring 3h after finishing.20 DEG C are cooled to, is filtered, filter cake is used A small amount of isopropanol washing, 45 DEG C of vacuum drying 12h, obtains white solid, and a small amount of methanol of solid is beaten washing 12h, is filtered, Gu Body is dried in vacuo 12h at 45 DEG C, obtains white solid 153g, yield:90%.
1HNMR(DMSO-d6):1.50ppm(m,8H),1.50ppm(m,8H),1.91-2.12ppm(s,6H),2.66- 2.81ppm(t,6H),3.94ppm(t,2H),5.09ppm(s,2H),6.61ppm(dd,1H),6.75ppm(m,4H),6.84- 7.16ppm(d,6H),9.69ppm(s,3H)。
Method II
By 150 grams of 1- { 4- [2- (hexamethylene ammonia) ethyoxyl] benzyl } -2- (4- hydroxy phenyls) -3- methyl -5- hydroxyls In the ascorbic acid input reaction kettle of base-indoles (formula (III)), 3000ml methyl tertiary butyl ether(MTBE)s and 1.5g, nitrogen protection, heating Reflux dissolving filters off insoluble matter, and 29g glacial acetic acid is instilled in filtrate, and drop keeps 60 DEG C of stirring 3h after finishing.20 DEG C are cooled to, is filtered, Filter cake is washed with a small amount of methyl tertiary butyl ether(MTBE), and 45 DEG C of vacuum drying 12h obtain white solid, solid with a small amount of methanol is beaten and is washed 12h is washed, is filtered, solid is dried in vacuo 12h at 45 DEG C, obtains white solid 135g, yield:80%.
Method III
By 150 grams of 1- { 4- [2- (hexamethylene ammonia) ethyoxyl] benzyl } -2- (4- hydroxy phenyls) -3- methyl -5- hydroxyls In the ascorbic acid input reaction kettle of base-indoles (formula (III)), 3000ml ethyl acetate and 1.5g, nitrogen protection is heated to reflux Dissolving filters off insoluble matter, and 29g glacial acetic acid is instilled in filtrate, and drop keeps 60 DEG C of stirring 3h after finishing.20 DEG C are cooled to, is filtered, filter cake It is washed with a small amount of ethyl acetate, 45 DEG C of vacuum drying 12h obtain white solid, and a small amount of methanol of solid is beaten washing 12h, is taken out Filter, solid are dried in vacuo 12h at 45 DEG C, obtain white solid 147g, yield:87%.
Method IV
By 150 grams of 1- { 4- [2- (hexamethylene ammonia) ethyoxyl] benzyl } -2- (4- hydroxy phenyls) -3- methyl -5- hydroxyls In the ascorbic acid input reaction kettle of base-indoles (formula (III)), 3000ml acetonitriles and 1.5g, nitrogen protection is heated to reflux dissolving, Insoluble matter is filtered off, 29g glacial acetic acid is instilled in filtrate, drop keeps 60 DEG C of stirring 3h after finishing.20 DEG C are cooled to, is filtered, filter cake is with less Acetonitrile washing is measured, 45 DEG C of vacuum drying 12h obtain white solid, and a small amount of methanol of solid is beaten washing 12h, is filtered, solid exists 45 DEG C of vacuum drying 12h, obtain white solid 140g, yield:83%.

Claims (8)

  1. A kind of 1. method for preparing bazedoxifene acetate intermediate, it is characterised in that:II-a of formula and II-b of formula are in aprotic, polar Production II under the conditions of solvent and organic base are existing, reaction equation is as follows:
    Wherein, R2Preferably acetyl group, propiono or bytyry;
    R1、R3It is acetyl group;Or R1For bytyry, R3For propiono;Or R1For acetyl group, R3For propiono.
  2. 2. the method according to claim 1 for preparing bazedoxifene acetate intermediate, it is characterised in that:The non-matter of polarity Sub- solvent is selected from one kind or several of N,N-dimethylformamide, N-Methyl pyrrolidone, 1,4- dioxane, dimethyl sulfoxide (DMSO) Kind.
  3. 3. the method according to claim 1 or 2 for preparing bazedoxifene acetate intermediate, it is characterised in that:It is described organic Alkali is selected from the one or more of triethylamine, diisopropyl ethyl amine, tripropyl amine (TPA) or tri-n-butylamine.
  4. 4. the method according to claim 1 or 2 for preparing bazedoxifene acetate intermediate, it is characterised in that:Formula II-a with The molar feed ratio of Formula II-b is 1:1-2.5.
  5. 5. the method according to claim 1 or 2 for preparing bazedoxifene acetate intermediate, it is characterised in that:Formula II-a with The molar feed ratio of Formula II-b is 1:1.5-2.5.
  6. 6. the method according to claim 1 or 2 for preparing bazedoxifene acetate intermediate, it is characterised in that:Formula II-a with The molar feed ratio of Formula II-b is 1:2.2.
  7. 7. the method according to claim 1 or 2 for preparing bazedoxifene acetate intermediate, it is characterised in that:The reaction 8-12h is reacted at 90-130 DEG C.
  8. 8. the method according to claim 1 or 2 for preparing bazedoxifene acetate intermediate, it is characterised in that:The reaction 10h is reacted at 110 DEG C.
CN201410199104.XA 2014-05-12 2014-05-12 The preparation method of bazedoxifene acetate and its intermediate Active CN105085365B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410199104.XA CN105085365B (en) 2014-05-12 2014-05-12 The preparation method of bazedoxifene acetate and its intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410199104.XA CN105085365B (en) 2014-05-12 2014-05-12 The preparation method of bazedoxifene acetate and its intermediate

Publications (2)

Publication Number Publication Date
CN105085365A CN105085365A (en) 2015-11-25
CN105085365B true CN105085365B (en) 2018-06-19

Family

ID=54566794

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410199104.XA Active CN105085365B (en) 2014-05-12 2014-05-12 The preparation method of bazedoxifene acetate and its intermediate

Country Status (1)

Country Link
CN (1) CN105085365B (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI287018B (en) * 1999-09-13 2007-09-21 Wyeth Corp Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
CZ302358B6 (en) * 2007-07-25 2011-03-30 Zentiva, A. S. Novel crystalline salts of bazedoxifene
WO2011022596A2 (en) * 2009-08-21 2011-02-24 Dr. Reddy's Laboratories Ltd. Preparation of bazedoxifene and its salts
US8569483B2 (en) * 2011-06-21 2013-10-29 Divi's Laboratories, Ltd. Process for the preparation of bazedoxifene acetate and intermediates thereof
CN103709090A (en) * 2014-01-16 2014-04-09 江苏万特制药有限公司 Preparation method of bazedoxifene acetate and key intermediate thereof
CN103772261B (en) * 2014-03-04 2015-02-18 苏州立新制药有限公司 Preparation method of bazedoxifene

Also Published As

Publication number Publication date
CN105085365A (en) 2015-11-25

Similar Documents

Publication Publication Date Title
CN105111205B (en) A kind of preparation method of Pa Boxini
CN102060769B (en) Preparation method of tolvaptan
CN102746231A (en) Celecoxib preparation process
CN101735190A (en) Method for preparing baicalein
EA200801508A1 (en) HIGH PURE 17α-CYANOMETHYL-17β-HYDROXY-ESTRA-4.9-DIEN-3-HE AND ITS SYNTHESIS METHOD
CN101486753A (en) Novel method for synthesizing finasteroid
CN105085365B (en) The preparation method of bazedoxifene acetate and its intermediate
CN114685468A (en) Intermediate compound of medicine for treating hysteromyoma and preparation method thereof
CN101613271A (en) 3-alkoxyl group-6-carboxyl rhein or its pharmacologically acceptable salt and its production and application
CN114315729B (en) 1-benzyl-2, 4-diaryl imidazole compound, synthetic method and application thereof in resisting tumor
CN103508934A (en) Preparation method of gliclazide
CN102382034A (en) Synthetic method of N-amino-3-azabicyclo[3,3,0]octane hydrochloride
EP3527556B1 (en) Method for preparing deuterated imidazole diketone compound
CN108129531A (en) A kind of preparation method of hesperidin methyl
WO2020181860A1 (en) Method for preparing rivaroxaban intermediate
CN103864877B (en) A kind of preparation method of Abiraterone acetate
CN113061095B (en) Synthesis method of dinavilin hydrochloride
CN107586275A (en) A kind of diphenoxylate hydrochloride industrialized preparing process
CN106279020A (en) A kind of norfloxacin form D and preparation method thereof, preparation and application
CN106810487B (en) Efficient preparation method of bazedoxifene
CN103044238B (en) A kind of preparation method of racemic ketoprofen Isoleucine calcium
CN103880748A (en) Ivabradine hydrochloride structure analogue and preparation method and application thereof
CN102432594A (en) Method for preparing 1-(3-hydroxymethylpyridine-2-yl)-2-phenyl-4-methyl piperazine serving as medicinal intermediate
CN103554007B (en) Novel 4, 5-substituted-7-methyl formate indole diketone derivative and application thereof in antitumor drugs
CN103848879B (en) A kind of with Isosorbide-5-Nitrae-Androstenedione for the method for Progesterone prepared by raw material

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant